Get the Daily Brief
Latest Biotech News
Novel Genome Editing and Base Editing Techniques Enhance Precision Therapeutics
Emerging genome editing technologies continue to improve specificity in nucleotide modification without double-strand breaks. Recent developments include the evolution of cytosine base editors...
Biotech Financing and Market Trends Reflect Sector Adjustment Post-Pandemic
Biopharma fundraising totaled $28.7 billion in the first half of 2025, down 59% from 2024 but aligning with levels from recent years prior to record highs. Notable financings include Quantum-Si...
Cogent Biosciences Advances with Rare Disease Drug: Phase 3 Success and FDA Filing Likely
Cogent Biosciences announced positive Phase 3 trial results for its drug bezuclastinib targeting indolent systemic mastocytosis, an immune disorder that causes allergic-like and systemic symptoms....
FDA Approvals and Industry Challenges: KalVista’s HAE Drug Gains Clearance Amid Agency Morale Crisis
KalVista Pharmaceuticals received FDA approval for Ekterly (sebetralstat), an orally-delivered treatment for hereditary angioedema (HAE), marking a significant entry on the rare disease market....
Clinical Trial Setbacks: Jasper Therapeutics Faces Data Issues and Stock Drop
Jasper Therapeutics disclosed a compromised drug lot that affected data integrity in a Phase 1b/2a trial for its leading urticaria treatment, briquilimab. The issue has prompted uncertainty about...
Apogee Therapeutics Advances Atopic Dermatitis Pipeline with IL-13 Antibody Showing Promise
Apogee Therapeutics reported positive Phase 2 results for APG777, an anti-IL-13 antibody for atopic dermatitis, demonstrating a 71% reduction in disease severity over placebo and comparable...
Viome and Microsoft Partner to Integrate AI-Powered RNA Diagnostics for Preventive Healthcare
Viome Life Sciences announced a collaboration with Microsoft to deploy AI-enhanced, RNA-based molecular diagnostics for personalized nutrition and proactive healthcare. The partnership leverages...
Genomics Collaboration Set to Advance Early Diagnosis and Gene Editing Treatments in Abu Dhabi
The Abu Dhabi Department of Health has partnered with UCSF and the Innovative Genomics Institute to establish genome medicine centers integrating clinical care and CRISPR gene-editing...
Breakthrough in Brain Science: Adult Neurogenesis Confirmed in Human Hippocampus
Research led by Karolinska Institutet demonstrates ongoing adult neurogenesis in the human hippocampus using advanced single-nucleus RNA sequencing, flow cytometry, and spatial transcriptomics....
AI Leap in Fertility: Columbia’s STAR System Detects Sperm Missed by Human Experts
Columbia University's STAR (Sperm Tracking and Recovery) AI system identified 44 sperm cells in samples previously deemed 'sterile' by manual technicians, leading to a successful pregnancy. This...
University of Copenhagen Secures $109M Grant to Establish Protein Design Center
The Novo Nordisk Foundation awarded $109 million to the University of Copenhagen to launch a Center for Protein Design (CPD) targeting advancement in designed proteins for therapeutic, industrial,...
Health Tech Financing Surges: Digital Startups Raise $6.4 Billion amid AI Boom
Digital health startups in the U.S. attracted $6.4 billion in funding across 245 deals during the first half of 2025, driven by strong investor enthusiasm for AI applications in healthcare. This...
Viome and Microsoft Partner for RNA-Driven Preventive Health
Viome Life Sciences has partnered with Microsoft to integrate AI-powered RNA-based molecular diagnostics into personalized healthcare. This collaboration leverages Viome's gene expression data...
Apogee's IL-13 Antibody Shows Promise for Eczema Treatment
Apogee Therapeutics reported positive Phase 2 trial results for its anti-IL-13 antibody APG777 in atopic dermatitis, achieving a 71% reduction in eczema severity after 16 weeks. The treatment met...
FDA Approvals and Challenges Impacting Biotech Sector
The FDA approved KalVista Pharmaceuticals’ sebetralstat for hereditary angioedema, representing a vital new therapeutic option for rare swelling disorders. Meanwhile, the agency faces deepening...
Cogent Biosciences Advances Mastocytosis Drug Toward FDA Approval
Cogent Biosciences announced that its phase 3 trial for bezuclastinib in indolent systemic mastocytosis met the primary endpoint, positioning the drug for potential FDA approval. The compound...
University of Copenhagen Secures $109M Grant for Protein Design Center
The Novo Nordisk Foundation awarded $109 million to the University of Copenhagen to establish a Center for Protein Design (CPD), aiming to become a European leader in synthetic protein...
AI Breakthrough Finds Viable Sperm in Previously Sterile Samples
Columbia University’s STAR AI system detected 44 sperm cells in male infertility samples previously deemed sterile by manual embryologist review. By adapting astrophysics star-detection...
New Evidence Confirms Adult Human Brain Neurogenesis
Researchers at Karolinska Institutet provided direct evidence of ongoing neurogenesis in the adult human hippocampus, identifying proliferating neural progenitor cells through single-nucleus RNA...
Clinical Innovation Insights: Trial Trailblazers Podcast Series
The 'Trial Trailblazers' podcast offers an inside look at groundbreaking clinical research across diverse therapeutic areas, including rare pediatric diseases, Alzheimer's natural killer cell...